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to mammals, the enzyme is expressed in a sole molecular form in several microorganism species (9) (10) (11) (12) . It belongs to the large family of protein tyrosine phosphatases (PTPs) that are divided into four subfamilies: the tyrosine specific phosphatases, the VH1-like dual specificity phosphatases, the cdc25 phosphatases, and the low molecular weight phosphatases. All PTPs have the active site signature sequence CXXXXXR, and all share the same catalytic mechanism (13) . Arginine is involved in substrate binding, whereas cysteine performs the nucleophilic attack on the substrate phosphorus atom, producing a covalent enzyme-phosphate intermediate, whose hydrolysis is the limiting step of the catalytic process. An aspartic acid residue assists the nucleophilic reaction by donating a proton to the leaving group in the transition state.
While the function of LMW-PTP in microorganisms is still debated (10, 12) , several papers produced in the last few years have indicated that the enzyme participates in the tyrosine kinase receptor function (14) (15) (16) (17) (18) . Specifically, the enzyme is involved in the down-regulation of PDGF and insulin receptors (14) (15) (16) . In the case of the PDGF receptor, the overexpression of the enzyme in NIH-3T3 cells [both as wild-type and as a dominant-negative (dn) mutant (C12S), a form able to bind substrates but catalitically inactive] produces opposite phenotypic effects: the wild-type enzyme decreases cell growth rate, whereas the dn-mutant increases it. The analysis of this action mechanism demonstrated that LMW-PTP binds and dephosphorylates the activated receptor in vivo. In particular, LMW-PTP is involved in pathways that regulate the transcription of the early genes myc and fos in response to growth factor stimulation.
Recent reports have also demonstrated that LMW-PTP is localized constitutively in cytosol and cytoskeleton, and that upon growth factor stimulation c-Src is able to bind by guest on July 7, 2017 http://www.jbc.org/ Downloaded from 5 and phosphorylate only the cytoskeleton-associated enzyme. As a consequence of its phosphorylation, LMW-PTP increases its activity about 20-fold, and this strongly influences both cellular adhesion and migration. The target of cytoskeleton associated LMW-PTP is p190Rho-GAP, which is phosphorylated on tyrosine after PDGF-stimulation (19) . In the case of insulin signaling, the specific involvement of the enzyme in the Src pathway has been demonstrated. Overexpression of the dn form of the enzyme also influences glucose uptake and glycogen synthesis upon insulin stimulation (16) .
Finally, the involvement of LMW-PTP in the regulation of other growth factor receptors has been reported. Stein et al. (20) have found that LMW-PTP is involved in the ephrine-B1 receptor function; Rigacci et al. (18) and Rovida et al. (17) , respectively, have shown that the fibroblast growth factor receptor and the macrophage colony-stimulating factor receptor functions are regulated by LMW-PTP.
In this paper we demonstrate that tyrosine-phosphorylated caveolin is a potential physiological substrate for LMW-PTP.
EXPERIMENTAL PROCEDURES
Materials --Human recombinant LMW-PTP was prepared as previously described (21) . Monoclonal anti-phosphotyrosine (PY-20) and polyclonal anti-caveolin (sc-894) antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Monoclonal anti-phosphocaveolin (PY14) antibody was purchased from Transduction Laboratories (Lexington, KY, USA). The sc-894 antibody is raised against a peptide corresponding to amino acids 2-21 mapping at the amino-terminus of caveolin-1, while the PY-14 monoclonal antibody is raised against a tyrosine-phosphorylated 6 peptide corresponding to amino acids 9-18 mapping at the amino-terminus of caveolin-1. Rabbit polyclonal anti-LMW-PTP antibody was produced in our laboratory. Protein A-Sepharose beads was from SIGMA. Soluble PTP-1B (recombinant glutathione-S-transferase fusion protein corresponding to full-length human PTP-1B) was purchased from Upstate Biotechnology, New York. 
Detergent-free Purification of Caveolin-rich Membrane Fractions --Low-density
caveolae-enriched domains were isolated as described by Song et al. (24) . Briefly, one confluent 100-mm dish, washed twice with ice-cold phosphate-buffered saline (PBS: 10 mM sodium phosphate and 0.15 M NaCl, pH 7.2), was scraped into 0.5 ml of sodium carbonate buffer (500 mM sodium carbonate, pH 11, 25 mM 4-morpholineethanesulfonic acid, 150 mM NaCl, and 1 mM phenylmethanesulfonyl fluoride, 1 µg/ml leupeptin, 1 µg/ml aprotinin). Cells were homogenized extensively using a Dounce homogenizer (50 strokes). The homogenate was then adjusted to 45
by guest on July 7, 2017 http://www.jbc.org/ Downloaded from 8 % sucrose by the addition of 0.65 ml of 80 % sucrose in 25 mM MES, 150 mM NaCl, and 1 mM phenylmethanesulfonyl fluoride, 1 µg/ml leupeptin, 1 µg/ml aprotinin, and placed at the bottom of an ultracentrifuge tube. A 5-35% discontinuous sucrose gradient was formed above the 45% layer, by adding 2.5 ml of 35% sucrose and 1.3 ml of 5% sucrose, both in 250 mM sodium carbonate, pH 11, 25 mM MES, 150 mM NaCl, and 1 mM phenylmethanesulfonyl fluoride, 1 µg/ml leupeptin, 1 µg/ml aprotinin.
The gradient was centrifuged at 170,000 × g for 20 h using a Beckman SW50.1 rotor.
For the analysis of the resulting gradient, 0.35 ml fractions were collected from the top to the bottom of the gradient. The insoluble pellet (fraction 15) was dissolved into 50 µl of Laemmli sample buffer. Western blot analysis was performed using both anticaveolin and anti-LMW-PTP antibodies.
Immunoprecipitation Experiments --Confluent NIH-3T3 cells overexpressing C12S dnLMW-PTP cultured in 100 mm dishes were washed with PBS, lysed in ice-cold lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1 % Triton X-100, 60 mM noctylglucoside, 2 mM EDTA, 1 mM orthovanadate, 100 mM NaF, 1 mM phenylmethanesulfonyl fluoride, 1 µg/ml leupeptin, 1 µg/ml aprotinin) and insoluble material was removed by centrifugation at 10,000 × g for 10 min. Lysate (500 µg of Other phosphotyrosine-containing proteins were also dephosphorylated, but more slowly. A similar pattern was observed using lysates from pervanadate-treated NIH-3T3 cells (data not shown).
In order to verify the specificity of LMW-PTP in comparison with other tyrosine phosphatases, we carried out the same experiment on the cell lysate using PTP1B
instead of LMW-PTP. The result is reported in Fig. 1C : PTP1B has the capacity to dephosphorylate a broad range of tyrosine phosphorylated protein substrates. 
LMW-PTP associates with Caveolae-Enriched Membrane Domains in vivo, and
Coimmunoprecipitates with Caveolin --The rationale of the following experiments, performed on NIH-3T3 fibroblasts overexpressing wild-type or dominant negative LMW-PTPs, is to demonstrate both the localization of LMW-PTP in caveolae and to investigate the mechanism of its recruitment into these membrane domains. We lysed confluent cells and then separated the caveolae-enriched membrane domains from other cellular components, using the density gradient centrifugation technique western-blot shows that caveolin is present in the lysates (Fig. 4C) , but the PY-20
antibody does not reveal phosphorylated caveolin (Fig. 4A) . Nevertheless, westernblot analysis performed with the monoclonal antibody PY-14 (which recognizes Tyr14-phosphorylated caveolin with high specificity) shows that upon insulin treatment caveolin phosphorylation is strongly enhanced in neoNIH-3T3IR cells,
indicating that a tyrosine kinase activated upon insulin-signaling is involved (Fig. 4B,   lanes 1 and 2) . The overexpression of the dominant negative LMW-PTP causes an increase in caveolin phosphorylation level both in untreated and in insulin-stimulated cells as compared to the control cells (Fig. 4B) . Moreover, we demonstrated that in these cells caveolin coimmunoprecipitates with LMW-PTP (Fig. 4 panels D, E, and F), and that the amount of immunoprecipitated caveolin is not dependent on its phosphorylation. In the control cells, immunoprecipitation with the anti-LMW-PTP antibody does not result in detectable LMW-PTP levels (Fig. 4F, lanes 1 and 2) .
Nonetheless, the samples contain significant amounts of immunoprecipitated caveolin (Fig. 4D) . We think that this is due to the low basal level of LMW-PTP in control cells; in contrast, caveolin is revealed in the immonoprecipitate because it forms homooligomers (31) , which may interact with other proteins with an unknown stoichiometry. There is increasing evidence that caveolae play a major role in organizing signal transduction at the cell surface (3, 34) . Different hormone receptors and signal transducers are localized in caveolae, and specific signaling events originate in caveolae, including the EGF-dependent activation of Raf-1 (35), IL-1 β stimulated production of ceramide (36), and PDGF receptor kinase cascade (37) . Furthermore, caveolin-1 is directly involved in the modulation of the activity of heterotrimeric GTPbinding proteins in vitro (38) . Thus caveolae may be involved in the organization of 
